Cargando…
Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and Pyrosequencing
Targeted therapies and, more precisely, EGFR tyrosine kinase inhibitors (TKIs) have been a major improvement in the therapeutic management of EGFR-mutated non-small-cell lung cancers (NSCLCs). Earlier administration of these TKIs throughout tumor progression is imperative to improve patient outcomes...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460542/ https://www.ncbi.nlm.nih.gov/pubmed/32751202 http://dx.doi.org/10.3390/diagnostics10080527 |
_version_ | 1783576626132418560 |
---|---|
author | Billaud, Amandine Verriele, Veronique Dauvé, Jonathan Chevalier, Louise-Marie Morel, Alain |
author_facet | Billaud, Amandine Verriele, Veronique Dauvé, Jonathan Chevalier, Louise-Marie Morel, Alain |
author_sort | Billaud, Amandine |
collection | PubMed |
description | Targeted therapies and, more precisely, EGFR tyrosine kinase inhibitors (TKIs) have been a major improvement in the therapeutic management of EGFR-mutated non-small-cell lung cancers (NSCLCs). Earlier administration of these TKIs throughout tumor progression is imperative to improve patient outcomes. Consequently, studies have focused on refining the characterization of biomarkers, especially concerning the resistance mutation p.Thr790Met of EGFR. Herein, we developed peptide nucleic acid (PNA)-mediated PCR clamping followed by pyrosequencing, favoring enrichment of the mutated fraction. A preamplification step was first added to increase the amplifiable DNA fraction. Throughout the application of our method on DNA extracted from FFPE samples of 46 patients with NSCLC who had relapsed under first-generation EGFR TKI, we evaluated a sensitivity of 93.3% and a specificity of 100%. All 19 patients who were positive for the p.Thr790Met mutation with NGS were also found to be positive with our protocol. The only discordant case was a sample with no mutation detected with NGS, but which was positive with PNA. This protocol allows for the detection of the p.Thr790Met mutation with a sensitivity of 0.5% which will permit earlier detection and an improvement of therapeutic management. |
format | Online Article Text |
id | pubmed-7460542 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74605422020-09-03 Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and Pyrosequencing Billaud, Amandine Verriele, Veronique Dauvé, Jonathan Chevalier, Louise-Marie Morel, Alain Diagnostics (Basel) Article Targeted therapies and, more precisely, EGFR tyrosine kinase inhibitors (TKIs) have been a major improvement in the therapeutic management of EGFR-mutated non-small-cell lung cancers (NSCLCs). Earlier administration of these TKIs throughout tumor progression is imperative to improve patient outcomes. Consequently, studies have focused on refining the characterization of biomarkers, especially concerning the resistance mutation p.Thr790Met of EGFR. Herein, we developed peptide nucleic acid (PNA)-mediated PCR clamping followed by pyrosequencing, favoring enrichment of the mutated fraction. A preamplification step was first added to increase the amplifiable DNA fraction. Throughout the application of our method on DNA extracted from FFPE samples of 46 patients with NSCLC who had relapsed under first-generation EGFR TKI, we evaluated a sensitivity of 93.3% and a specificity of 100%. All 19 patients who were positive for the p.Thr790Met mutation with NGS were also found to be positive with our protocol. The only discordant case was a sample with no mutation detected with NGS, but which was positive with PNA. This protocol allows for the detection of the p.Thr790Met mutation with a sensitivity of 0.5% which will permit earlier detection and an improvement of therapeutic management. MDPI 2020-07-29 /pmc/articles/PMC7460542/ /pubmed/32751202 http://dx.doi.org/10.3390/diagnostics10080527 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Billaud, Amandine Verriele, Veronique Dauvé, Jonathan Chevalier, Louise-Marie Morel, Alain Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and Pyrosequencing |
title | Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and Pyrosequencing |
title_full | Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and Pyrosequencing |
title_fullStr | Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and Pyrosequencing |
title_full_unstemmed | Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and Pyrosequencing |
title_short | Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and Pyrosequencing |
title_sort | non-small-cell lung cancer-sensitive detection of the p.thr790met egfr alteration by preamplification before pna-mediated pcr clamping and pyrosequencing |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460542/ https://www.ncbi.nlm.nih.gov/pubmed/32751202 http://dx.doi.org/10.3390/diagnostics10080527 |
work_keys_str_mv | AT billaudamandine nonsmallcelllungcancersensitivedetectionofthepthr790metegfralterationbypreamplificationbeforepnamediatedpcrclampingandpyrosequencing AT verrieleveronique nonsmallcelllungcancersensitivedetectionofthepthr790metegfralterationbypreamplificationbeforepnamediatedpcrclampingandpyrosequencing AT dauvejonathan nonsmallcelllungcancersensitivedetectionofthepthr790metegfralterationbypreamplificationbeforepnamediatedpcrclampingandpyrosequencing AT chevalierlouisemarie nonsmallcelllungcancersensitivedetectionofthepthr790metegfralterationbypreamplificationbeforepnamediatedpcrclampingandpyrosequencing AT morelalain nonsmallcelllungcancersensitivedetectionofthepthr790metegfralterationbypreamplificationbeforepnamediatedpcrclampingandpyrosequencing |